PHARMAZEUTISCHE FORMULIERUNGEN
European patent · EP2205280 · In force
Register entry
- Publication number
- EP2205280
- Application number
- EP08833819
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Sep 29, 2008
- Published
- Jul 14, 2010
- Granted
- Sep 4, 2019
- Protection ends at the latest
- Sep 28, 2028
- Next annual fee due
- Sep 30, 2027
- IPC classes
- A61K 9/00 (2006.01)A61K 47/22 (2006.01)A61K 47/24 (2006.01)A61K 39/395 (2006.01)A61K 9/19 (2006.01)A61K 47/18 (2017.01)
- Priority
- US 975780 P 27.09.2007
- PCT application
- PCT/US2008/078193 29.09.2008
- PCT publication
- WO2009/043049 02.04.2009
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Oct 1, 2026
Next annual fee due on
- Next annual fee due on
- 30.09.2026 → 30.09.2027
Published in Swissreg on 01.10.2026
- Oct 1, 2025
Next annual fee due on
- Next annual fee due on
- 30.09.2025 → 30.09.2026
Published in Swissreg on 01.10.2025
- Oct 3, 2024
Change
Published in Swissreg on 03.10.2024
- Oct 1, 2023
Change
Published in Swissreg on 01.10.2023
- Oct 1, 2022
Change
Published in Swissreg on 01.10.2022
- Sep 4, 2019
Granted
Published in Swissreg on 04.09.2019
Parties
Inventor
LI, Tiansheng
Newbury Park CA 91320, US
KO, Jason
Thousand Oaks CA 91360, US
VERGARA, Camille
Calabasas CA 91302, US
SLOEY, Christopher, James
Oak Park CA 91377, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.